An existing drug for HIV could double as a preventative therapy for Alzheimer’s disease, according to researchers. NRTIs (nucleoside reverse transcriptase inhibitors) are antivirals that are ...

A new blood test test could determine how far Alzheimer's has progressed and could also help confirm whether another condition is causing a person’s cognitive symptoms.

Omega-3 fatty acids, huperzine A, and synthetic coenzyme Q10 have been proven in clinical trials to be no better than placebo (i.e., like a sugar pill) for Alzheimer's disease patients, according ...

A recent study hints that individuals in the early stages of Alzheimer's may have difficulties with turning while walking. Health experts from University College London (UCL) used virtual reality ...

With the number of Americans living with the disease steadily increasing, scientists predict that 13.8 million will have Alzheimer’s by 2050, or 16% of the US population over the age of 65 ...

The Lumipulse Alzheimer's blood test is the first of a new generation of tests that may replace brain scans and spinal taps to detect the disease. advertisement What to know about Lumipulse.

A cholinergic agonist first developed in the 1990s for Alzheimer’s disease, xanomeline, was approved last year in combination with trospium chloride, a side-effect blocker, for the treatment of ...

Disproven alternative therapies for treating cognitive symptoms in Alzheimer's disease include omega-3 fatty acids, huperzine A, and synthetic coenzyme Q10, according to the Alzheimer's Association.

A new report suggests up to 7.2 million Americans ages 65 and older are living with Alzheimer’s disease, an increase of about 300,000 cases of the mind-robbing disease from a year ago.. The ...

The Alzheimer's Association's latest estimate, released in a report Tuesday, said around 7.2 million in the U.S. have the disease. It's the first time there's been more than 7 million. Advertisement ...

Alzheimer's affects an estimated 7.2 million people in the U.S. age 65 and over, with 74 percent of those patients aged 75 or older, according to the Alzheimer's Association 2025 Disease Facts and ...

An emerging class of treatments may provide a new way of treating Alzheimer’s. Anti-amyloid medications work inside the brain to prevent Alzheimer’s disease from progressing.